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no episode of rastenosis either within the stent or at the stant edges. IVUS results (Table) 
show no difference when SE stent edges were compared to placebo stent edges. To the 
contrary, there was a tendency for reference lumen areas to be larger and plaque areas 
to be smaller in SE stants, especially at the distal edge. 
SE etent Bare etlmt A p-value 
N=48 N=47 
Proximal edge 
Artedal area, mm 2 14.76+5.05 13.89-1"3.69 0.87 0.37 
Lumen area, mm 2 7.65-J:3.37 6.84+~.61 0.81 0.22 
Plaque area, mm 2 7.11:~2..90 7.05:P.2.52 -0.06 0.91 
Distal edge 
Arfedal area, mm 2 11.59~:4.08 11.46+3.70 0.13 0.88 
Lumen area, mm 2 6.68+~.30 5.69~1.91 0.99 0.03 
Plaque area, mm 2 4.90+_2.53 5.77:P.2.97 0.86 0.16 
Basel~e MSA (sqrnm) Bmllne MSA (Nmm) 
Conclusions: Volumetric IVUS analysis shows that there is no "edge effect' when siroli- 
mus-eluting stants are used to treat de novo, native coronary lesions. 
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Value of Min imum Stent Area for Long-Term Stent 
Patency 
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Seung-Ho Hur, Paul G. Yock, Peter J. Fitzgerald, SCORE investigators group, Stanford 
University, Stanford, California, Heart Center Siogburg, Siegburg, Germany, 
Minimum stant area (MSA) has been shown to be a consistent predictor of instant rest- 
enosis. However, its predictive value is limited because of biologic variability in the rest- 
enosis process. Drug-eluting stents (DES) provide a biological effect as well as a 
mechanical solution to obstructive lesions. The aim of this study was to investigate the 
relationship between post-procedure MSA and long-term stent patancy following the 
QUANAM QP2-eluting stent (DES) implantation as compared to bare metal stents 
(BMS). 
Methods: SCORE is a randomized trial comparing DES vs. BMS. To date, serial IVUS 
(baseline and 6-months) studies are available in 64 (DES 30: BMS 34) of 118 enrolled 
patients. MSA at post-procedure and minimum lumen area (MLA) at follow-up were 
obtained. 
Results: The baseline charactadstics were similar in DES and BMS. In BMS, only a 
weak correlation was observed between post-procedure MSA and follow-up MLA 
(r--0.37, p--0.03), potentially reflecting high variability in biological activity of individual 
lesion/patients. DES, however, showed a significant positive relationship with a high cor- 
relation coefficient between the two parameters (r=0.73, p<0.0001). 
Conclusions: Preliminary IVUS results suggest that past-procedure MSA may predict 
long-term stent patancy more accurately in DES than in BMS. This finding indicates that 
post-procedure MSA, a simple mechanical index, can be used as the optimal procedural 
endpoint for DES, regardless of variable degrees of biological activity in each lesion. 
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Background: We previously showed, in a non-rendomized study, that Sirolimus-Eluting 
(SE) stents inhibit noeintimal proliferation. These preliminary results were tested in 
RAVEL, a double-blinded, randomized, placedo-controlled multicentar trial that com- 
pared SE BX Velocity stents (n=120) vs bare BX Velocity stenta (BS, n=118). Methods: 
The intravascular ultrasound (IVUS) sub-study included 95 pts (SE=48 and BS=47). 
Results: 
6-Month IVUS FU Sirolimus-eluting Bare stant P values 
Stant volume (mm3) 130.6-3:33.9 132:1:1 +35.6 0.842 
Lumen volume (ram3) 128.9~33.9 94.9.~40.9 < 0.0001 
Intimal hyperplasia volume (ram 3) 1.97+4.87 37.2¢27.8 < 0.0001 
Intimal hyperplesla (% of stant volume) 1.45:1:2.83 28.8+19.7 < 0.0001 
The cumulative frequency distribution curve of percent obstruction shows that 90% of the 
SE group had less than 2% of the stent occupied by neointima (left curve, Figure). Con- 
cluslons: In the RAVEL trial, IVUS analysis shows a striking inhibition of intimal hyper- 
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Bogart Parra, Ron Waksman, Peter J. Fitzgerald, Paul G. Yock, Stanford University 
School of Medicine, Stanford, California, Hospital "Miguel Pdrez Carrsr~o', Caracas, 
Venezuela. 
BACKGROUND: Late effects of intracoronary gamma radiation remain unknown, as 
moot long-term studies of efficacy and potential side effects have been initiated within the 
past 3 years. We report five-year intravascular ultrasound (IVUS) findings from the initial 
cohort of patients treated with intrecoronary brechytherepy in Venezuela. 
METHOD: IVUS examinations were performed in 14 patients (15 lesions) 5 years after 
they were treated with non-centered 1921r in doses of 19-55 Gy after PTCA. IVUS inter- 
rogations were performed by manual pullback using a dynamic aperture catheter system 
(in-Vision, EndoSonioo Corp., Rancho Cordova, CA) and were analyzed off-line using 
quantitative methods (QCU) by a commercially available software package (Quent32, 
Sanders Data Systems, Palo Alto, CA). 
RESULTS: At5 years, the mean minimum lumen area (MLA) atthe treated segment was 
3.6¢1.9 ram2 (range, 0 to 8 ram), and the mean % area stenosis (%AS) at the irradiated 
segment was 50.5:P.22.9 (range, 19.4 to 100 %). IVUS defined (%AS >70%) restenosis 
was present in 4 arteries (26.7%), two of which occurred at edges. Positive remodeling 
was obsewed in 9 artedes (60%), and three true coronary aneurysms were observed (2 
focal, 1 fusiform) without evidence of thrombus, increased echo intensity of adventitia, 
presumably due to fibrosis, of moderate or greater degree occurred in 11 artades 
(73.3%). Calcification was observed in 9 arfedes (60%), mostly as >90 degree arcs and 
of deep or mixed location. 
CONCLUSIONS: In this five-year IVUS cohort, gamma radiation was associated with 
modest plaque/neointima ccumulation. Positive remodeling was common and there 
were three aneurysms (previously detected by anglo). The most striking new finding was 
fibrosis of the adventitia nd extensive deep and mixed calcification in the majodty of the 
treated segments. 
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A recent volumetric IVUS study has suggested the role of peri-stent remodeling in subse- 
quent neointimal response. The aim of this study was to investigate the potential relation- 
ship between peri-stent remodeling and neointimal proliferation following intracoronary 
brechytherepy with a beta source wire (32p). 
Methods: Sedal (baseline and follow-up) volumetric IVUS analyses were performed in 
23 stentad lesions treated with intrecoronary beta radiation enrolled in the PREVENT 
study. Vessel (W), stent (SV) and lumen volumes (LV) were obtained using Simpaon's 
method. The volumes of plaque and neointima outside the stent (ped-stant volume, PSV) 
and neointima within the stent (intrastent volume, ISV) were computed. Peri-stant remod- 
eling was defined present if AVV > 0 (Group P) and absent if AVV_<0 (Group N). 
Results: At baseline, W, LV, SV, PSV and ISV were similar between Group P (n=12) 
